NextTrip, Inc 8-K, filed Aug 28, 2020
NextTrip, Inc. (NTRP)
About this 8-K
NextTrip, Inc filed this 8-K on August 28, 2020, reporting on events of August 25, 2020.
Items reported
- Item 8.01: Other events
UNITEDSTATES
SECURITIESAND EXCHANGE COMMISSION
WASHINGTON,D.C. 20549
FORM8-K
CURRENTREPORT
PURSUANTTO SECTION 13 OR 15(D) OF THE
THESECURITIES EXCHANGE ACT OF 1934
Dateof report (Date of earliest event reported): August 25, 2020
SIGMALABS, INC.
(Exact name of registrant as specified in its charter)
| Nevada | 001-38015 | 27-1865814 |
|---|---|---|
| (State<br> or other jurisdiction of<br><br> incorporation or organization) | (Commission<br><br><br> File Number) | (I.R.S.<br> Employer <br><br> Identification No.) |
3900 Paseo del Sol
Santa Fe, New Mexico 87507
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (505) 438-2576
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written<br> communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|---|---|
| [ ] | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title<br> of each class | Trading<br> Symbol(s) | Name<br> of each exchange on which registered |
|---|---|---|
| Common<br> Stock, par value $0.001 per share | SGLB | The<br> NASDAQ Stock Market LLC |
| Warrants<br> to Purchase Common Stock, par value $0.001 per share | SGLBW | The<br> NASDAQ Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
| Item<br> 8.01 | Other<br> Events. |
|---|
On August 25, 2020, warrants (the “Preferred Warrants”) to purchase an aggregate of 3,568 shares of Series D Convertible Preferred Stock (the “Preferred Shares”) of Sigma Labs, Inc. (the “Company”) were exercised by four accredited investors, resulting in gross proceeds to the Company of $3,478,800. In connection with the exercise of the Preferred Warrants and the subsequent conversion of Preferred Shares, the Company issued an aggregate of 1,895,049 shares of the Company’s common stock. Following such exercise, 392 Preferred Warrants remain outstanding out of a total of 6,156 Preferred Warrants initially issued.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date:<br> August 28, 2020 | SIGMA LABS, INC. | |
|---|---|---|
| By: | /s/ Mark K. Ruport | |
| Name: | Mark<br> K. Ruport | |
| Title: | President<br> and Chief Executive Officer |